CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Catalent to divest UK site; Rottendorf, Evonik announce manufacturing builds

Neutral
AI Analysis

Summary

Catalent is divesting its oral solid dose manufacturing facility in Nottingham, UK to Codis. The article also mentions manufacturing announcements from Rottendorf and Evonik.

Importance:4/10
Sentiment:
0.00
divestituremanufacturingCDMOfacility sale
Related Companies

Read the original article

Published by Endpoints News on July 9, 2026 1:43 PM

Read Original